Go to main text Go to main menu

InBody

About InBody

History of InBody

Early 1990's Dr. Kichul Cha recognized
BIA devices were inaccurate,
making them useless to the
medical industry.

1996

InBody was founded in South Korea. Products feature direct segmental multi-frequency bioelectrical impedance analysis (DSM-BIA) and an eight-point tactile electrode system to measure an individual’s body composition without the use of empirical data.

2000

InBody established its first overseas subsidiary in Beverly Hills, California. InBody technology is FDA approved and results have been validated by research.

2009

GE Healthcare Strategic Business Partnership

2012

InBody moved its corporate office from
Beverly Hills to Cerritos, California.

2013

The InBody 570, capable of measuring segmental fat analysis including visceral fat level, is released.

2014

The InBody 770, a new research-grade body composition analyzer is launched and the InBody 570 wins the Red Dot Design Award.

2015

iF DESIGN AWARD is given to the InBody 770.
InBody receives the 2015 Foreign Direct Investment Award from the Los Angeles Chamber of Commerce during World Trade Week.

InBody BAND and InLab win CES 2015 Innovation Award for wearable technologies.

InBody unveiled the InBody BAND, the world’s first wearable body composition device.

2016

Lookin’BodyWeb, a cloud-based data software is launched.
The InBody PUSH, a handheld, portable stadiometer is released for the first time in the United States.

The InBody 270, designed specifically for professionals who need to analyze body composition on-the-go, goes on sale.

2017

InBody releases the InBody BAND 2, a second-generation wearable body composition device. The BAND 2 features EZTrainingTM, which automatically tracks exercises.

2019

The InBody BPBIO 320S, is launched in April. The InBody H20N, is launced in May.